• Regulatory Services in Germany

    Overview

    With its universal healthcare system, Germany offers a good deal of business opportunities for medicines / medical device manufacturers. The Federal Institute for Drugs and Medical Devices, Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) oversees / regulates respective Regulatory activities in the region. With the world’s oldest healthcare system and with many reforms followed by, the Regulatory regime in Germany stands one of the toughest to deal with while approaching for necessary registrations and approvals.

  • Pharma Regulatory Services in Germany

    Overview

    Pharmaceutical market in Germany has displayed a continued growth over the years. As a prominent member of European Union (EU), Germany requires a Market Authorization (MA) granted by the country’s Ministry of Health (MoH) to market and distribute medicinal products locally. As per the Directive 2001/83/EC, any new medicinal product shall be registered through a Marketing Authorization Application (MAA) following certain procedures: